A Prospective Randomized, Controlled Pilot Study in Order to Evaluate the Place of Thymoglobuline in Non-myeloablative Allogeneic Hemapoietic Stem-cell Transplantation (NST).
Phase of Trial: Phase III
Latest Information Update: 22 Feb 2011
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 01 Apr 2009 Primary endpoints identified as reported by ClinicalTrials.gov.
- 26 Nov 2007 Status changed from recruiting to completed.
- 26 Feb 2006 New trial record.